Insomnia symptoms affect suicide risk among people who drink alcohol

Insomnia symptoms affect the risk of suicide among people who drink alcohol, according to a groundbreaking study led by the director of Mississippi State University's Sleep, Suicide and Aging Laboratory.

Principal investigator Michael R. Nadorff, an assistant professor of psychology, headed the multi-institutional team representing MSU, Baylor College of Medicine in Houston, Emory University's School of Medicine in Atlanta, and the Veterans Integrated Service Network 19 in Glendale, Colorado.

The new study—the first of its kind—demonstrates how wakefulness is connected to the relationship between alcohol use and suicide risk. The work also details how professional assessment and treatment of specific sleep problems may reduce the suicide risk for people who drink alcohol.

"Though our study is preliminary, based upon these findings and the broader literature, patients and clinicians should consider insomnia as an additional warning sign of potential suicidal behavior, not just a symptom of other warning signs, such as depression or alcohol use," Nadorff said.

The national Centers for Disease Control and Prevention list suicide as the 10th leading cause of U.S. deaths, while excessive alcohol use is connected to approximately 88,000 deaths annually.

"We examined whether insomnia symptoms explained a significant portion of the relation between alcohol symptoms and suicide risk," said Nadorff, a West Virginia University doctoral graduate who completed a doctoral internship at Baylor's College of Medicine. "We found that for both men and women, insomnia symptoms explained a significant amount of the variance in the relation between alcohol use and suicide risk."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption